Return On Assets of Nuo Therapeutics, Inc. from 30 Jun 2011 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
- Summary
-
Nuo Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2011 to 31 Dec 2025.
- Nuo Therapeutics, Inc. Return On Assets for the quarter ending 31 Dec 2025 was -160%, a 4.1% increase year-over-year.
- Nuo Therapeutics, Inc. annual Return On Assets for 2025 was -160%, a 4.1% increase from 2024.
- Nuo Therapeutics, Inc. annual Return On Assets for 2024 was -167%, a 6.8% increase from 2023.
- Nuo Therapeutics, Inc. annual Return On Assets for 2023 was -179%, a 74% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)
Nuo Therapeutics, Inc. Quarterly Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | -160% | +6.8% | +4.1% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | -173% | -14% | -9.1% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | -183% | -7.1% | -4.1% | 01 Apr 2025 | 30 Jun 2025 |
| Q1 2025 | -172% | +26% | +13% | 01 Jan 2025 | 31 Mar 2025 |
| Q4 2024 | -167% | +12% | +6.8% | 01 Oct 2024 | 31 Dec 2024 |
| Q3 2024 | -158% | +10% | +6% | 01 Jul 2024 | 30 Sep 2024 |
| Q2 2024 | -175% | -38% | -28% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -198% | -90% | -83% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -179% | -76% | -74% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -169% | -83% | -98% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -137% | -58% | -74% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -109% | -43% | -67% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -103% | -84% | -448% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -85% | +77% | +48% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -79% | +143% | +64% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -65% | +284% | +81% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -19% | +191% | +91% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -163% | -441% | -158% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -222% | -373% | -247% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -349% | -72% | -26% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -209% | +304% | +59% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | 278% | +495% | 01 Jul 2020 | 30 Sep 2020 | |
| Q2 2020 | 151% | +397% | 01 Apr 2020 | 30 Jun 2020 | |
| Q1 2020 | -277% | -72% | -35% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | -514% | -339% | -194% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | -217% | +779% | +78% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | -245% | +71% | +23% | 01 Apr 2019 | 30 Jun 2019 |
| Q1 2019 | -205% | +55% | +21% | 01 Jan 2019 | 31 Mar 2019 |
| Q4 2018 | -175% | +7.5% | +4.1% | 01 Oct 2018 | 31 Dec 2018 |
| Q3 2018 | -996% | -984% | -8132% | 01 Jul 2018 | 30 Sep 2018 |
| Q2 2018 | -317% | -287% | -954% | 01 Apr 2018 | 30 Jun 2018 |
| Q1 2018 | -260% | -249% | -2315% | 01 Jan 2018 | 31 Mar 2018 |
| Q4 2017 | -182% | 01 Oct 2017 | 31 Dec 2017 | ||
| Q3 2017 | -12% | +388% | +97% | 01 Jul 2017 | 30 Sep 2017 |
| Q2 2017 | -30% | +442% | +94% | 01 Apr 2017 | 30 Jun 2017 |
| Q1 2017 | -11% | +300% | +97% | 01 Jan 2017 | 31 Mar 2017 |
| Q3 2016 | -400% | -382% | -2155% | 01 Jul 2016 | 30 Sep 2016 |
| Q2 2016 | -472% | -474% | -19569% | 05 May 2016 | 30 Jun 2016 |
| Q1 2016 | -310% | -295% | -1891% | 01 Jan 2016 | 31 Mar 2016 |
| Q4 2015 | -168% | -136% | -417% | 01 Oct 2015 | 31 Dec 2015 |
| Q3 2015 | -18% | +30% | +63% | 01 Jul 2015 | 30 Sep 2015 |
| Q2 2015 | 2.4% | +54% | 01 Apr 2015 | 30 Jun 2015 | |
| Q1 2015 | -16% | +28% | +64% | 01 Jan 2015 | 31 Mar 2015 |
| Q4 2014 | -33% | +10% | +23% | 01 Oct 2014 | 31 Dec 2014 |
| Q3 2014 | -48% | -7.3% | -18% | 01 Jul 2014 | 30 Sep 2014 |
| Q2 2014 | -51% | -13% | -35% | 01 Apr 2014 | 30 Jun 2014 |
| Q1 2014 | -43% | -0.96% | -2.3% | 01 Jan 2014 | 31 Mar 2014 |
| Q4 2013 | -43% | -1.2% | -2.9% | 01 Oct 2013 | 31 Dec 2013 |
| Q3 2013 | -41% | -2.4% | -6.3% | 01 Jul 2013 | 30 Sep 2013 |
| Q2 2013 | -38% | +7.4% | +16% | 01 Apr 2013 | 30 Jun 2013 |
| Q1 2013 | -42% | -6.6% | -18% | 01 Jan 2013 | 31 Mar 2013 |
| Q4 2012 | -41% | -6.5% | -19% | 01 Oct 2012 | 31 Dec 2012 |
| Q3 2012 | -38% | -14% | -57% | 01 Jul 2012 | 30 Sep 2012 |
| Q2 2012 | -45% | -35% | -357% | 01 Apr 2012 | 30 Jun 2012 |
| Q1 2012 | -36% | 01 Jan 2012 | 31 Mar 2012 | ||
| Q4 2011 | -35% | 01 Oct 2011 | 31 Dec 2011 | ||
| Q3 2011 | -24% | 01 Jul 2011 | 30 Sep 2011 | ||
| Q2 2011 | -9.9% | 01 Apr 2011 | 30 Jun 2011 |
Nuo Therapeutics, Inc. Annual Return On Assets (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | -160% | +6.8% | +4.1% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | -167% | +12% | +6.8% | 01 Jan 2024 | 31 Dec 2024 |
| 2023 | -179% | -76% | -74% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -103% | -84% | -448% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -19% | +191% | +91% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -209% | +304% | +59% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -514% | -339% | -194% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | -175% | +7.5% | +4.1% | 01 Jan 2018 | 31 Dec 2018 |
| 2017 | -182% | 01 Jan 2017 | 31 Dec 2017 | ||
| 2015 | -168% | -136% | -417% | 01 Jan 2015 | 31 Dec 2015 |
| 2014 | -33% | +10% | +23% | 01 Jan 2014 | 31 Dec 2014 |
| 2013 | -43% | -1.2% | -2.9% | 01 Jan 2013 | 31 Dec 2013 |
| 2012 | -41% | 01 Jan 2012 | 31 Dec 2012 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.